» Authors » Damien Blez

Damien Blez

Explore the profile of Damien Blez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 59
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vignals C, Emmerich J, Begueret H, Garcia-Hermoso D, Martin-Blondel G, Angoulvant A, et al.
Emerg Infect Dis . 2024 May; 30(6):1077-1087. PMID: 38781681
Scedosporium spp. and Lomentospora prolificans are emerging non-Aspergillus filamentous fungi. The Scedosporiosis/lomentosporiosis Observational Study we previously conducted reported frequent fungal vascular involvement, including aortitis and peripheral arteritis. For this article,...
2.
Lafont E, Blez D, Bildan M, Veyer D, Pere H, Puech J, et al.
Clin Infect Dis . 2023 Dec; 79(3):798-800. PMID: 38159041
No abstract available.
3.
Dubert M, Kably B, Derobertmasure A, Podglajen I, Munte L, Clauss D, et al.
J Antimicrob Chemother . 2023 Oct; 78(12):2915-2918. PMID: 37878769
Objectives: Treating patients with infective endocarditis (IE) due to streptococci and enterococci currently involves high-dosage antibiotics. Recent literature suggests a 30%-70% diffusion rate could be extrapolated to human heart valve...
4.
Blez D, Bronnimann D, Rammaert B, Zeller V, Delhaes L, Hustache L, et al.
Med Mycol . 2023 Feb; 61(3). PMID: 36813259
Little is known about localized osteoarticular Scedosporiosis (LOS). Most data come from case reports and small case series. Here we present an ancillary study of the nationwide French Scedosporiosis Observational...
5.
Rolland S, Kassis-Chikhani N, Auclin E, Bensaid S, Bidaud A, Gerlinger M, et al.
Eur J Clin Microbiol Infect Dis . 2022 Dec; 42(2):161-168. PMID: 36472717
We aimed to describe the outcome of totally implantable venous-access port (TIVAP)-related infections due to Gram-negative aerobic bacilli (Pseudomonas aeruginosa and other Pseudomonas spp., Acinetobacter spp., and Stenotrophomonas maltophilia), or...
6.
Blez D, Soulier A, Bonnet F, Gayat E, Garnier M
Intensive Care Med . 2020 Aug; 46(11):2094-2095. PMID: 32737522
No abstract available.
7.
Blez D, Blaize M, Soussain C, Boissonnas A, Meghraoui-Kheddar A, Menezes N, et al.
Haematologica . 2019 Jun; 105(2):478-489. PMID: 31171644
The Bruton tyrosine kinase inhibitor ibrutinib has become a leading therapy against chronic lymphoid leukemia. Recently, ibrutinib has been associated with the occurrence of invasive fungal infections, in particular invasive...